Back to search
FDAFDA · Food and drugs·Recall number D-0494-2026

Levocarnitine Injection, USP, 1 g/5 mL (200 mg/mL), 5 mL Single-Dose Vial, For intravenous use, Rx Only, American Regent, Inc., Shirley, NY 11967. NDC: 0517-1045-01

Published May 6, 2026 · Recall initiated: April 16, 2026

Summary

FDA records drug Class III recall D-0494-2026, published May 6, 2026 and initiated April 16, 2026. Recalling firm: American Regent, Inc.; Status: Ongoing; Reported quantity: 74,040 Single Dose Vials; Lot: Lot 24159N0C0, Exp. June 30, 2026 Lot 25193N0C0, Exp. July 31, 2027. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Missing Label

What to do

Voluntary: Firm initiated · Letter

Get an email if LEVOCARNITINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
LEVOCARNITINE
Manufacturer
American Regent, Inc.
Distributor
U.S. Nationwide
Lot
Lot 24159N0C0, Exp. June 30, 2026 Lot 25193N0C0, Exp. July 31, 2027
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Levocarnitine Injection, USP, 1 g/5 mL (200 mg/mL), 5 mL Single-Dose Vial, For intravenous use, Rx Only, American Regent, Inc., Shirley, NY 11967. NDC: 0517-1045-01 recalled?

Yes. FDA published recall D-0494-2026 on May 6, 2026. Reported hazard: Labeling: Missing Label

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: LEVOCARNITINE.